Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
NTR Quote, Financials, Valuation and Earnings
Last price:
$58.33
Seasonality move
:
5.7%
Day range:
$58.45 - $59.83
52-week range:
$43.70 - $65.08
Dividend yield:
3.71%
P/E ratio:
54.64x
P/S ratio:
1.12x
P/B ratio:
1.19x
Volume:
2.6M
Avg. volume:
2.1M
1-year change:
14.83%
Market cap:
$28.5B
Revenue:
$26B
EPS (TTM):
$1.07
Earnings Data
Next earnings date for NTR
Aug 06
2025
Most recent earnings per share
$0.02
Missed by $0.28
(May 7/2025)
Consensus Estimate
$0.30
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NTR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $5.4B | -- | -- | $0.77 | -- |
| 08/06/2025 | Q2 | $10.4B | -- | -- | $2.40 | -- |
| 05/07/2025 | Q1 | $5.1B | $5.1B | $0.02 | $0.30 | -$0.28 |
| 02/19/2025 | Q4 | $5.1B | $5.1B | $0.23 | $0.36 | -$0.13 |
| 11/06/2024 | Q3 | $5.2B | $5.3B | $0.04 | $0.45 | -$0.41 |
| 08/07/2024 | Q2 | $10.7B | $10.2B | $0.78 | $2.19 | -$1.41 |
| 05/08/2024 | Q1 | $5.2B | $5.4B | $0.32 | $0.38 | -$0.06 |
| 02/21/2024 | Q4 | $5.2B | $5.7B | $0.35 | $0.65 | -$0.30 |
| 11/01/2023 | Q3 | -- | -- | $0.15 | $0.64 | -$0.49 |
| 08/02/2023 | Q2 | -- | -- | $0.89 | $2.78 | -$1.89 |
| 05/10/2023 | Q1 | -- | -- | $1.14 | $1.48 | -$0.34 |
| 02/15/2023 | Q4 | -- | -- | $2.15 | $2.57 | -$0.42 |
| 11/02/2022 | Q3 | -- | -- | $2.94 | $3.94 | -$1.00 |
| 08/03/2022 | Q2 | -- | -- | $6.51 | $5.70 | $0.81 |
| 05/02/2022 | Q1 | -- | -- | $2.49 | $2.78 | -$0.29 |
| 02/16/2022 | Q4 | -- | -- | $2.11 | $2.38 | -$0.27 |
| 11/01/2021 | Q3 | -- | -- | $1.25 | $1.23 | $0.02 |
| 08/09/2021 | Q2 | -- | -- | $1.94 | $2.10 | -$0.16 |
| 05/03/2021 | Q1 | -- | -- | $0.22 | $0.09 | $0.13 |
| 02/18/2021 | Q4 | -- | -- | $0.55 | $0.18 | $0.37 |
| 11/03/2020 | Q3 | -- | -- | -$1.03 | $0.13 | -$1.16 |
| 08/11/2020 | Q2 | -- | -- | $1.34 | $1.35 | -$0.01 |
| 05/06/2020 | Q1 | -- | -- | -$0.06 | -$0.07 | $0.01 |
| 02/19/2020 | Q4 | -- | -- | -$0.08 | $0.24 | -$0.32 |
| 11/05/2019 | Q3 | -- | -- | $0.24 | $0.42 | -$0.18 |
| 07/29/2019 | Q2 | -- | -- | $1.58 | $1.58 | $0.00 |
| 05/09/2019 | Q1 | -- | -- | $0.20 | $0.25 | -$0.05 |
| 02/06/2019 | Q4 | -- | -- | $0.54 | $0.53 | $0.01 |
| 11/06/2018 | Q3 | -- | -- | $0.47 | $0.44 | $0.03 |
| 08/02/2018 | Q2 | -- | -- | $1.48 | $1.40 | $0.08 |
| 05/07/2018 | Q1 | -- | -- | $0.16 | $0.23 | -$0.07 |
| 02/05/2018 | Q4 | -- | -- | -- | $0.41 | -- |
Nutrien Earnings Questions
-
How Much did Nutrien Generate in Revenue Last Quarter?
Nutrien reported $5.1B worth of top line sales in its most recent quarter.
-
Did Nutrien Beat Earnings Last Quarter?
Nutrien announced earnings per share of $0.02 which represents a miss of analyst forecast a $0.30 per share.
-
Is Nutrien Profitable?
Nutrien reported $1.3B that represents $2.70 per share over the last quarter.
-
What is the Analyst Consensus for Nutrien EPS Next Year?
Nutrien's earnings are forecast to grow from $1.36 per share to $3.57 per share next year representing an increase of 197.77%.
-
When is Nutrien's Earnings Date?
Nutrien's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
